Nov. 12, 2024 — Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of ... Oct. 8, 2024 ...

Gain Therapeutics' GT-02287 shows promise in treating Parkinson's disease, with positive results and potential for market ...

Human Amniotic Epithelial Stem Cells is under clinical development by iCELL Biotechnology and currently in Phase I for Parkinson's Disease.

Best three wishes to ask a genie funny 91-year-old Nobel Prize winner Professor Corey of Harvard University synthesizes chiral α-amino ketones in the latest JACS Shijiazhuang Pharmaceutical's ...

rummy cutter Shijiazhuang Pharmaceutical's idiopathic Parkinson's disease drug "Pramipexole Hydrochloride Tablets" was approved, becoming the first Fosun Pharma's first new drug Avatrombopag approved ...

INR:9916. milan matka ka chart Shijiazhuang Pharmaceutical's idiopathic Parkinson's disease drug "Pramipexole Hydrochloride Tablets" was approved, becoming t ...

Powerplay join a league R&D Daily丨BGI's COVID-19 nucleic acid detection kit passed PMDA certification Shijiazhuang Pharmaceutical's idiopathic ...

king matka result Bayer 2019 financial report: China market grew by 25%; Chloroquine phosphate tablets fight against the epidemic Shijiazhuang Pharmaceutical's idiopathic Parkinson's disease drug ...

The Company has received approval to begin enrollment of the Phase 1b clinical trial in AustraliaPhase 1b clinical trial will assess safety and ...

Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in ...

Although air pollution is linked to increased exacerbations in patients with idiopathic pulmonary fibrosis (IPF), its role in disease progression remains uncertain, with evidence suggesting that ...